We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.85B
AUM Growth
-$202M
Cap. Flow
-$288M
Cap. Flow %
-15.59%
Top 10 Hldgs %
31.04%
Holding
450
New
28
Increased
86
Reduced
211
Closed
50

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$59.2M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$55.1M
3
BAC icon
Bank of America
BAC
+$21.4M
4
ABT icon
Abbott
ABT
+$16.5M
5
GL icon
Globe Life
GL
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 19.46%
2 Energy 16.48%
3 Industrials 10.8%
4 Financials 10.7%
5 Technology 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UN
76
DELISTED
Unilever NV New York Registry Shares
UN
$5.28M 0.29%
91,940
-103
-0.1% -$6.08K
AKAM icon
77
Akamai
AKAM
$16.4B
$5.27M 0.29%
60,999
+272
+0.4% +$23.8K
CBRE icon
78
CBRE Group
CBRE
$42.1B
$5.19M 0.28%
84,618
-335
-0.4% -$18.6K
RDS.B
79
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5.04M 0.27%
84,011
-1,889
-2% -$111K
NGD
80
DELISTED
New Gold Inc
NGD
$4.99M 0.27%
5,669,425
-446,150
-7% -$404K
FURY
81
Fury Gold Mines
FURY
$101M
$4.98M 0.27%
2,330,438
YELP icon
82
Yelp
YELP
$1.45B
$4.95M 0.27%
142,064
-1,015
-0.7% -$34.4K
OGE icon
83
OGE Energy
OGE
$10.2B
$4.86M 0.26%
109,344
+332
+0.3% +$14.3K
USAS
84
Americas Gold and Silver
USAS
$1.37B
$4.78M 0.26%
603,409
-51,333
-8% -$367K
MDT icon
85
Medtronic
MDT
$108B
$4.71M 0.26%
41,515
-282
-0.7% -$30.9K
RRC icon
86
Range Resources
RRC
$8.85B
$4.57M 0.25%
941,769
-191,000
-17% -$770K
NVDA icon
87
NVIDIA
NVDA
$4.76T
$4.42M 0.24%
751,520
+144,200
+24% +$750K
MA icon
88
Mastercard
MA
$487B
$4.39M 0.24%
14,692
-35
-0.2% -$9.87K
PAAS icon
89
Pan American Silver
PAAS
$18.6B
$4.3M 0.23%
181,400
-110,000
-38% -$2.04M
CONE
90
DELISTED
CyrusOne Inc Common Stock
CONE
$4.23M 0.23%
64,588
+12,370
+24% +$849K
SEIC icon
91
SEI Investments
SEIC
$12.2B
$4.21M 0.23%
64,220
-86
-0.1% -$5.35K
GLD icon
92
SPDR Gold Trust
GLD
$132B
$4.12M 0.22%
28,838
-1,100
-4% -$154K
VG
93
DELISTED
Vonage Holdings Corporation
VG
$3.99M 0.22%
538,566
+517,528
+2,460% +$4.47M
QCOM icon
94
Qualcomm
QCOM
$179B
$3.99M 0.22%
45,194
-39
-0.1% -$3.26K
KMB icon
95
Kimberly-Clark
KMB
$37B
$3.89M 0.21%
28,306
-779
-3% -$105K
FF icon
96
Future Fuel
FF
$203M
$3.71M 0.2%
299,450
FOE
97
DELISTED
Ferro Corporation
FOE
$3.56M 0.19%
240,385
-10,280
-4% -$133K
WOW
98
DELISTED
WideOpenWest
WOW
$3.56M 0.19%
479,811
+74,341
+18% +$471K
GSK icon
99
GSK
GSK
$104B
$3.56M 0.19%
60,515
+5,273
+10% +$293K
CVS icon
100
CVS Health
CVS
$137B
$3.53M 0.19%
47,487
-262
-0.5% -$18.4K

Similar funds

Ingalls & Snyder LLC's Q4 2019 Portfolio in Review

As of Q4 2019, Ingalls & Snyder LLC held 450 positions worth $1.85B, down 9.9% from $2.05B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ingalls & Snyder LLC withdrew a net $288M in Q4 2019, closing 50 positions and reducing 211 holdings. Its most notable exit was Apple, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Energy and Industrials.

Against the trend, Ingalls & Snyder LLC opened a new position in ROSETTA STONE INC worth $539K.

  • Ingalls & Snyder LLC's largest Q4 2019 buy was ROSETTA STONE INC: 29,710 shares worth $539K.
  • Ingalls & Snyder LLC added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.86M increase.
  • Ingalls & Snyder LLC's biggest Q4 2019 reduction was Corcept Therapeutics, cutting an estimated $9.71M.
  • Ingalls & Snyder LLC fully exited Apple in Q4 2019, selling an estimated $59.2M.
  • Ingalls & Snyder LLC's ten largest holdings make up 31% of its $1.85B portfolio in Q4 2019.
  • Ingalls & Snyder LLC opened 28 new positions and closed 50 in Q4 2019.
  • Ingalls & Snyder LLC's portfolio value fell 9.9% quarter-over-quarter to $1.85B.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.